March 17, 2009 – Sorin Group recently announced the enrollment of the first three patients in a clinical trial aimed at obtaining European market approval for its Perceval S Sutureless Aortic Heart Valve.
March 16, 2009 - St. Jude Medical Inc. today announced FDA clearance of the newest version of the Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.
March 17, 2009 - Clinical pharmacology company Cetero Research and centralized cardiac testing company Cardiocore announced today a global strategic alliance to optimize the design, conduct and reporting of cardiac safety studies.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 16, 2009 - LUMEDX Corp. and Mennen Medical said today they signed a strategic partnership agreement to provide a total, integrated cath lab data solution and seamless stream of hemodynamic cardiovascular patient data to their customers.
Patients with chronic conditions such as congestive heart failure use Honeywell HomMed’s Genesis DM telehealth monitor from the comfort of their own homes to daily measure vital signs such as heart rate, blood pressure and weight.
March 16, 2009 - TeraRecon reported that it has achieved greater than 10,000 licensed concurrent users globally for its Aquarius advanced visualization solution, and claims that the figure gives the company the largest market share in the direct-to-end-user market for advanced visualization.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 16, 2009 - Cordis Corp. said today it plans to launch a global, head-to-head, randomized clinical trial called NEVO II, which will compare the NEVO sirolimus-eluting coronary stent to the XIENCE V everolimus-eluting coronary stent. Cordis and Conor Medsystems LLC are sponsors of the study.
March 16, 2009 – Invatec today announced CE-certification of a new coronary balloon, the IN.PACT Falcon paclitaxel-eluting PTCA balloon catheter, which is one of the first drug-eluting balloons designed specifically to treat atherosclerosis in the coronary arteries.
March 16, 2009 - Frost & Sullivan said it will be naming the recipients of its 2009 Excellence in Medical Technologies & Life Sciences Awards at a banquet that will take place on Wednesday, March 18, 2009, in San Francisco, CA.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 16, 2009 – Today the Access to Medical Imaging Coalition (AMIC), a coalition of physician, patient and imaging manufacturer groups, will hold a media conference to unveil a new analysis on Medicare claims data from 1998 – 2007 for advanced imaging services (CT, MR and Nuclear Medicine (including PET).
March 13, 2009 - Medical testing meets medical texting with the FDA’s clearance of GE Healthcare’s latest ECG (electrocardiogram) solution, the portable MAC 800, which is based on cell phone technology.
March 13, 2009 - Details from the DAVID (Dual Chamber and VVI Implantable Defibrillator) II Trial suggest atrial pacing may be considered a safe alternative to ventricular pacing, but affords no clear advantage over a mode that minimizes pacing. The results of the study were published this week in the March 10, 2009, issue of the Journal of the American College of Cardiology (JACC).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 13, 2009 – HIMSS said today that with less than a month before HIMSS 2009, total conference registration parallels the record-breaking registration figures during this same time frame for last year’s show.
March 13, 2009 - A comprehensive analysis published this week in The Lancet from the ABSORB clinical trial demonstrated that Abbott’s bioabsorbable drug eluting stent (DES), currently in development, successfully treated coronary artery disease and was absorbed into the walls of treated arteries within two years.
March 13, 2009 - BridgePoint Medical Inc. completed the first human clinical case in the U.S. using its CrossBoss CTO Catheter and Stingray CTO Re-Entry System.